Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000449 · ClinicalTrials.gov registry record · Phase 4
Behavior and Naltrexone Treatment for Alcoholics
A Phase 4 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
NCT00000449 is a Phase 4 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 160 participants.
The verdict
NCT00000449, a Phase 4 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
Study Summary
The study's purpose is to improve alcoholism treatment by investigating the combined effectiveness of a psychotherapy (Coping Skills Training and Cue Exposure Treatment - CSTCET) with naltrexone in a randomized clinical trial. Individuals will receive 2 weeks of CSTCET or a control treatment as inpatients followed by 12 consecutive weeks of receiving either naltrexone or placebo as outpatients. Followups at 24, 48, and 72 weeks after treatment is completed.
Interventions
- BEHAVIORAL cognitive behavioral therapy
- DRUG naltrexone (Revia)
- BEHAVIORAL cue exposure treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Est. Completion | 2000-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000449
The ClinicalTrials.gov registry entry for NCT00000449 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which cognitive behavioral therapy is the first listed.
NCT00000449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000449 about?
NCT00000449 is a clinical study titled "Behavior and Naltrexone Treatment for Alcoholics". The study's purpose is to improve alcoholism treatment by investigating the combined effectiveness of a psychotherapy (Coping Skills Training and Cue Exposure Treatment - CSTCET) with naltrexone in a randomized clinical trial. Individuals will receive 2 weeks of CSTCET or a control treatment as inpa...
What is the current status of trial NCT00000449?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 160 participants. Estimated completion is 2000-03.
What interventions are being tested in trial NCT00000449?
The interventions under investigation include: cognitive behavioral therapy (BEHAVIORAL), naltrexone (Revia) (DRUG), cue exposure treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000449?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.